NIH awards contracts for COVID-19 rapid point-of-care tests
The National Institutes of Health last week announced as part of its Rapid Acceleration of Diagnostics initiative $129.3 million in contracts to nine companies for technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can return results within 24 hours.
Among the tests are some that use RT-PCR and a device that can give results in 15 minutes and strips that can be read without specialized equipment, similar to pregnancy tests.
In addition, NIH said it is adding five additional laboratories to expand the network of coverage and potentially manage tens of thousands of additional tests daily.
Related News Articles
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…